Enfortumab vedotin-ejfv (PADCEV)
Grashma Vadakkel, PharmD | Feb 10, 2021 8:18:59 AM Bladder cancer is the sixth most common cancer in the United States. Patients with locally advanced or metastatic disease have poor long-term…
Engaging Specialty Pharmacies to Help Patients Cover the Cost of Therapy
Ana Begley | Feb 10, 2021 8:23:36 AM According to recent studies, nearly 1 in 4 adults in the United States who are taking prescription medications, expressed difficulty affording their prescription…
Serving as Team Lead in a Quality Improvement Project
Natalie Halladay, MS, RN, FNP-BC, AOCNP® | Feb 10, 2021 8:23:10 AM Quality Improvement (QI) in the healthcare setting has evolved in recent years to improve outcomes in clinical practice.1 In 2010,…
HPV-Associated head and neck cancer: Racial Disparities in Outcomes
Faith Mutale, MSN, CRNP | Feb 10, 2021 8:17:51 AM Although risk factors for squamous-cell cancer of the head and neck (SCCHN) have been identified (e.g., tobacco use, alcohol use, human…